NLM Digital Collections

Search

Start Over Subjects United States ✖Remove constraint Subjects: United States Dates by Range 2000 and later ✖Remove constraint Dates by Range: 2000 and later

3891. Bempedoic acid and inclisiran for patients with heterozygous familial hypercholesterolemia and for secondary prevention of ASCVD: final policy recommendations

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, March 2, 2021
Subject(s):
Cardiovascular Diseases -- prevention & control
Cholesterol, LDL -- antagonists & inhibitors
Hypercholesterolemia -- drug therapy
United States

3893. Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report

Author(s):
Tice, Jeffrey A., author
Herron-Smith, Serina, author
Tsiao, Emily, author
Chapman, Rick M., author
Zaim, Remziye, author
Segel, Celia, author
Rind, David, author
Pearson, Steven D., author
Guzauskas, Greg, author
Hansen, Ryan N., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, July 10, 2019
Subject(s):
Immunotherapy
Peanut Hypersensitivity
United States

3896. Esketamine for the treatment of treatment-resistant depression: effectiveness and value : final evidence report

Author(s):
Atlas, Steven, author
Agboola, Foluso, author
Fazioli, Katherine, author
Fluetsch, Noemi, author
Kumar, Varun, author
O'Grady, Madeline, author
Rind, David, author
Pearson, Steve, author
Touchette, Daniel R., author
Boyer, Nicole, author
Talon, Brian, author
Schultz, Bob G., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Depressive Disorder, Treatment-Resistant -- drug therapy
Hallucinogens -- therapeutic use
United States

3897. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

Author(s):
Wasfy, Jason H., author
Walton, Surrey M., author
Beinfeld, Molly, author
Nhan, Emily, author
Sarker, Jyotirmoy, author
Whittington, Melanie D., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 16, 2021
Subject(s):
Cardiac Myosins -- antagonists & inhibitors
Cardiomyopathy, Hypertrophic -- drug therapy
United States

3898. Tezepelumab for severe asthma: final report

Author(s):
Rind, David M., author
McQueen, Brett, author
Herron-Smith, Serina, author
Herce-Hagiwara, Belén, author
Gutierrez, Éric, author
Fluetsch, Noemi, author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 16, 2021
Subject(s):
Antibodies, Monoclonal, Humanized
Asthma -- drug therapy
United States

3899. Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Sharaf, Ravi, author
Synnott, Patricia, author
Samur, Sumeyye, author
Chapman, Rick M., author
Adair, Ellie, author
Rind, David, author
Pearson, Steve, author
O'Grady, Madeline, author
Bloudek, Lisa, author
Carlson, Josh J., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, June 20, 2019
Subject(s):
Multiple Sclerosis, Chronic Progressive -- drug therapy
Sphingosine 1 Phosphate Receptor Modulators
United States

3900. Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report

Author(s):
Rind, David M., author
Walton, Surrey M., author
Agboola, Foluso, author
Herron-Smith, Serina, author
Quach, Danny, author
Chapman, Rick M., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 20, 2020
Subject(s):
Antibodies, Monoclonal
Genetic Therapy
Hemophilia A -- drug therapy
United States